Response to toripalimab combined with radiotherapy in advanced non-small cell lung cancer-not otherwise specified: A case report

RATIONALE: The targeting of signal transduction through programmed cell death receptor-1 (PD-1) and its ligand programmed cell death-ligand 1 (PD-L1) in patients with non-small cell lung cancer (NSCLC) has been widely applied in clinical research. However, the subtypes and treatment patterns that pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yonglong, Xiao, Wenjing, Wang, Xintong, Cui, Yinshi, Li, Bo, Liu, Xiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542166/
https://www.ncbi.nlm.nih.gov/pubmed/34678907
http://dx.doi.org/10.1097/MD.0000000000027581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542166/
https://www.ncbi.nlm.nih.gov/pubmed/34678907
http://dx.doi.org/10.1097/MD.0000000000027581

Ejemplares similares